How Wellness Programs Compare in Cost-Effectiveness to Other Benefit Investments

If you're weighing a wellness budget against every other line in your benefits stack, the honest answer is that "wellness programs" isn't one investment. It's a category that includes everything from a gym subsidy nobody uses to a clinically governed platform tied to therapy access and manager training. Comparing that category to, say, a 401(k) match or a parental leave expansion only works once you know which version of "wellness" you're actually running, and how many people are actually using it.

That second part is where most benefits leaders get stuck. You can build a spreadsheet with a cost-per-employee figure for every program type, but the number that actually determines cost-effectiveness rarely shows up on the invoice. It shows up in the utilisation report, and for a lot of legacy wellness spend, that report doesn't get pulled until renewal.

For a full breakdown of typical costs across initiative types, see our EAP and wellness cost-benefit comparison, which lays out the initiative-by-initiative numbers for EAPs, gym subsidies, mindfulness apps, wellness stipends, and health screenings. This piece picks up where that comparison leaves off: how to evaluate cost-effectiveness for your own program, rather than the category average.

Two organizations can buy the same benefit, price it the same, and get returns that aren't in the same order of magnitude. The variable isn't the program design. It's whether people use it, whether that use connects to a business outcome, and whether anyone can actually measure the connection.

This is the trap in most cost-effectiveness comparisons: they compare list price against list price, as if a wellness stipend that sits unused is competing fairly with a benefit employees actually engage with. It isn't. An unused benefit has a cost-effectiveness of zero, no matter how cheap it was to buy.

The category with the starkest version of this problem is the EAP. The average EAP sees under 2% engagement, and a legacy EAP running at 2 to 4% utilisation is providing legal cover rather than care. Kearney's prior international EAP utilisation was reported as low as 1% in some regions and never higher than 3% before they replaced it. Whatever that program cost per employee, the effective cost per person actually helped was many times higher, because the denominator that matters is people served, rather than people covered.

Before you can compare your wellness spend to anything else in the benefits budget, gather five things.

Utilisation, rather than enrollment. How many employees used the benefit in the last quarter, rather than how many are technically eligible. Enrollment tells you what you bought. Utilisation tells you what you're getting.

Depth of engagement, rather than just logins. A single login and a sustained pattern of use (repeat sessions, course completion, therapy bookings) are different signals. A benefit with modest reach but deep engagement among the people who need it most can outperform a benefit with broad but shallow adoption.

Escalation pathway. Does the program route people from self-help content into higher-acuity support, such as coaching or therapy, when they need it? A benefit that only serves the well-already population is solving a different problem than one built to catch issues before they escalate into absence or attrition.

Business outcome linkage. Can you connect usage to a metric your CFO already tracks, such as absence, turnover, or productivity, rather than only reporting satisfaction scores or Net Promoter Score. This is the difference between a benefit you can defend and one you can only describe.

Manager and leadership involvement. Programs that equip managers to have supportive conversations tend to sustain adoption longer than programs aimed only at individual employees, because managers are usually the actual point of daily influence over whether someone uses a benefit at all.

If you can't produce numbers for at least three of these five, you don't yet have enough information to compare your wellness spend fairly against other benefit categories. That's a data gap to close before it's a budget decision to make.

Run this exercise with your own numbers. Take your total annual wellness spend and divide it by enrolled employees to get a cost-per-employee figure. Then divide the same total spend by the number of employees who actually used the program in the past twelve months. The second number is your real cost-effectiveness figure, and for most legacy programs it's dramatically higher than the first.

This is why utilisation rate belongs at the center of any cross-category comparison, ahead of sticker price. A program priced lower per employee but used by 2% of the workforce can cost more per person helped than a program priced higher but used by 20 or 30%. This pattern shows up directly among Unmind customers: Who Gives A Crap reached 52% uptake within six months of replacing a legacy EAP, and Calix sustained around 30% engagement after consolidating onto a single platform. Neither number is a claim about what any other organization will see, but both illustrate the same point: utilisation is the variable that determines whether a program's list price bears any relationship to its actual cost-effectiveness.

There's also outcome data worth weighing alongside utilisation. A six-month study with a global FMCG employer, run across four countries, found a projected 3.49x ROI and roughly $1M in estimated productivity impact, with a 16% reduction in stress and a 10% reduction in work impairment among high-stress employees. Separately, investment in the Unmind platform has been associated with a $4.6 return for every $1 invested. These are the kinds of figures a benefits leader can put next to a program's cost, rather than relying on satisfaction scores alone.

When you're deciding where a wellbeing dollar goes relative to other benefits, a short list of direct questions does more work than a long RFP.

• What was actual utilisation last quarter, rather than eligibility?
• Does the vendor report outcomes (absence, productivity, retention) or only usage?
• What happens when someone needs more than self-help content? Is there a real pathway to human support?
• Is this program measured at the organizational level, or only through individual satisfaction surveys?
• If we consolidated three overlapping point solutions into one measured system, would utilisation improve because access got simpler?

That last question matters more than it looks. Fragmented wellbeing spend, an EAP here, a meditation app there, a separate coaching vendor, tends to suppress utilisation across the board because employees don't know which door to use. If your organization is running multiple overlapping wellbeing lines, the comparison worth making isn't wellness versus other benefits. It's the current fragmented spend versus a single, measured alternative. We've written more about that specific decision in our piece on consolidating employee wellbeing programs, which looks at the case for replacing scattered point solutions with one system rather than comparing program cost in isolation.

You don't need a full research study to get a directionally useful answer. Pull last quarter's utilisation numbers for your current wellness benefit. Cross-reference against absence or turnover data for the same population, even at a high level. Compare the resulting cost-per-person-helped figure against what you know about your other benefit lines, using the initiative-by-initiative cost data in the pillar comparison as your baseline. Then ask whether the gap between enrollment and utilisation is closing or widening year over year. A shrinking gap suggests a program that's earning its budget. A widening one is a signal to act before the next renewal cycle, rather than after.

This is also the reasoning behind the approach Unmind takes with Insights & Assessments, which aggregates wellbeing data into real-time dashboards so utilisation, stress signals, and engagement patterns are visible at the organizational level rather than buried in an annual vendor report. At Unmind, Nova, the AI coach, is built with the same measurement logic in mind, giving people a low-friction way in while still routing them to Therapy and Coaching when the need is higher acuity.

Cost-effectiveness in wellbeing spend isn't a category-level question. It's a utilisation-and-outcomes question, asked about the specific program your organization is running today. A wellness benefit priced competitively but used by almost nobody isn't cost-effective just because the invoice is small. A benefit with real uptake, a clear escalation path, and outcomes you can report to your CFO earns its place in the budget on its own terms, independent of what the category average looks like.

If you're ready to model what a measured, consolidated approach could return for your organization, unmind.com/roi walks through the ROI math behind the Unmind platform.